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2 
Abstract 23 
 The removal of protons (H+) produced during intense exercise is important for skeletal muscle 24 
function, yet it remains unclear how best to structure exercise training to improve muscle pH regulation.  25 
We investigated whether 4 weeks of work-matched, sprint-interval training (SIT), performed 3 days per 26 
week, with either 1 min (Rest-1; n = 7) or 5 min (Rest-5; n = 7) of rest between sprints, influenced 27 
adaptations in acid/base transport protein content, non-bicarbonate muscle buffer capacity (βmin vitro), 28 
and exercise capacity in active women.  Following one week of post-testing, comprising a biopsy, a 29 
repeated-sprint ability (RSA) test, and a graded-exercise test, maintenance of adaptations was then 30 
studied by reducing SIT volume to one day per week for a further 5 weeks.  After 4 weeks of SIT, there 31 
was increased protein abundance of monocarboxylate transporter (MCT)1, sodium/hydrogen exchanger 32 
(NHE)1, and carbonic anhydrase (CA)XIV for both groups, but rest interval duration did not influence 33 
the adaptive response.  In contrast, greater improvements in total work performed during the RSA test 34 
after 4 weeks of SIT was evident for Rest-5 compared to Rest-1 [effect size (ES): 0.51; 90% confidence 35 
limits ±0.37), whereas both groups had similarly modest improvements in V̇O2peak.  When training 36 
volume was reduced to one day per week, enhanced acid/base transport protein abundance was 37 
maintained, although NHE1 content increased further for Rest-5 only.  Finally, our data support 38 
intracellular lactate as a signaling molecule for inducing MCT1 expression, but neither lactate nor H+ 39 
accumulation appear to be important signaling factors in MCT4 regulation.  40 
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Introduction 45 
 High-intensity exercise demands a large non-mitochondrial ATP turnover and results in 46 
accumulation of protons (H+) in skeletal muscle, which have been implicated in excitation–contraction 47 
coupling inhibition (69), impairment of cross-bridge cycling (27), and inactivation of key glycolytic 48 
enzymes (74).  Mitigation of the exercise-induced reduction in intracellular pH (pHi) entails uptake of 49 
H+ by physicochemical buffers, such as histidyl-imidazole residues and inorganic phosphate (Pi), and 50 
buffering of H+ by metabolic reactions in parallel with energy production (48).  Acid/base transport 51 
across the sarcolemma by specific proteins provides a means to remove H+ from the myofiber, or to 52 
introduce bicarbonate (HCO3
−) or equivalents (CO3
2-,  NaCO3
− ) (50, 77).  Given the importance of pHi 53 
regulation for muscle function and exercise capacity, much research has focused on the effects of 54 
exercise training on acid/base transport proteins and muscle buffer capacity (βm).  Most of these studies 55 
have employed different modalities of high-intensity interval training [HIIT; repeated exercise bouts at 56 
intensities →100% maximal oxygen uptake (V̇O2max)], or sprint interval training [SIT; repeated exercise 57 
bouts at intensities ≥ 100% V̇O2max] (84).  However, equivocal findings to date indicate the stimuli 58 
required for upregulation of the individual components of pHi regulation remain to be determined. 59 
 The acid/base transport proteins can be categorized as either lactate (La−)-coupled or 60 
nonlactate-coupled.  The former comprises the monocarboxylate transport proteins (MCT1 and MCT4) 61 
and their chaperone protein basigin.  The latter consists of the sodium hydrogen exchanger (NHE) 62 
proteins, the skeletal muscle isoform being NHE1.  H+-equivalent transport is provided by the sodium-63 
coupled bicarbonate transporter (NCBT) family of proteins, of which, isoform-specific protein evidence 64 
has been shown for only the electrogenic sodium/bicarbonate cotransporter (NBCe)1 (63).  In addition, 65 
a functional, and perhaps physical interaction, has been demonstrated in vitro between each of these 66 
acid/base transport proteins and the skeletal muscle carbonic anhydrase (CA) isozymes (6).  While there 67 
has been much investigation of the response to training of the MCTs and NHE1, though little of these 68 
other proteins, the signaling networks responsible for regulation of any of the acid/base transport 69 
proteins remain poorly understood compared to, for example, the well-described Akt/mTOR and 70 
AMPK/PGC1-α pathways for resistance and endurance exercise, respectively (e.g. 29). 71 
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Notwithstanding this limited picture of transcriptional and translational events for the acid/base 72 
transporters, there must be an initial signal(s) activated by exercise that initiates a phenotypic change 73 
(65).  One such signal previously proposed for different acid/base transporters is the accumulation, or 74 
sustained production, of intracellular La−/H+ (38, 51, 53, 80).  Through manipulating the rest period 75 
between high-intensity work intervals, it should be possible to design contrasting exercise protocols 76 
that result in either high absolute La−/H+ levels, or sustained production of La−/H+.  For example, muscle 77 
pH has been shown to decrease even further in the first 90 s after a single 30-s sprint (17); therefore, 78 
exercise comprising high-intensity work intervals, interspersed with rest periods < 90 s, should result 79 
in large peaks in La−/H+.  However, given insufficient recovery of pHi between intervals may result in 80 
reduced glycogen phosphorylase (Phos) activity during subsequent intervals (74), sustained production 81 
of La−/H+ may require longer rest between work intervals.  With muscle pH recovering by ~50% within 82 
4–6 min after single or multiple sprints (8, 17, 64), similar duration rest periods may maximize 83 
anaerobic glycolysis for sequential intervals (74).  Ultimately, by manipulating rest interval duration, 84 
while matching intensity and total work, it may be possible to test whether different exercise-induced 85 
changes in intracellular La−/H+ subsequently influence upregulation of specific acid/base transport 86 
proteins. 87 
 In addition to the uncertainty as how best to elicit improvements in pHi-regulatory components, 88 
it is also not clear how detraining might be mitigated.  Adaptations of acid/base transport proteins to 89 
training have been shown to be transient following cessation of HIIT.  In a previous study (63), we 90 
found almost total reversal of adaptations in all of the acid/base transporters 6 weeks after completing 91 
4 weeks of HIIT.  Reductions in MCT1 and MCT4 abundance have similarly been reported 6 weeks 92 
after stopping SIT (18).  It is known that maintenance of some training-induced adaptations can be 93 
achieved, or dysregulation mitigated, by reducing the volume of training while maintaining the intensity 94 
(41, 42, 46, 47, 67).  Although, it is possible that fractional degradation of some or all the acid/base 95 
transport proteins can be mitigated by a reduced volume of high-intensity training, this hypothesis has 96 
not been tested. 97 
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 The present study therefore compared two different recovery durations between 30-s sprints 98 
during work-matched SIT.  We hypothesized that through altering the duration of the rest interval, 99 
subsequent variations in intracellular La−/H+ would influence the adaptive responses of the acid/base 100 
transport proteins.  In addition, we postulated that improvements in βm and exercise performance would 101 
reflect potential differences in substrate usage.  Finally, we proposed that performing SIT one day per 102 
week for 5 weeks, following a 4-week period of training 3 days per week, would be sufficient to 103 
maintain any potential adaptations in acid/base transport proteins, βm, and repeated-sprint ability. 104 
 105 
Materials & Methods 106 
Participants 107 
 Twenty-one recreationally-active women gave written informed consent to participate in this 108 
study.  Six participants withdrew during the familiarization period because of either unrelated 109 
illness/injury, or a lack of time, and one participant withdrew after the first SIT session (SIT1) because 110 
of an unwillingness to undergo further biopsies.  Fourteen participants completed the entire study [age: 111 
24 (6) y; height: 164.6 (3.8) cm; mass: 62.9 (7.8) kg; V̇O2peak: 39.3 (5.3) mL•min
−1•kg−1; mean (SD)].  112 
Before the training intervention began, weekly training load was 1,005 (593) arbitrary units [mean 113 
(SD)], calculated from session rating of perceived exertion and training duration (28).  All procedures 114 
were approved by the Victoria University Human Research Ethics Committee. 115 
Experimental Design 116 
 The study employed a two-group parallel design (Fig. 1).  There were two work-matched SIT 117 
groups, differing only in the duration of the rest component of the duty cycle – either 1-min rest (Rest-118 
1: n = 7) or 5-min rest (Rest-5: n = 7).  Following familiarization trials and pre-training tests, participants 119 
were ranked on total work performed during a repeated-sprint ability (RSA) test, and coded 120 
consecutively with either an A or a B in ABBA format.  Using random generation of binary numbers, 121 
type of training was then randomly allocated to group A (Rest-5) and group B (Rest-1). 122 
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 The study consisted of two training phases, participants trained three days per week for the first 123 
four weeks and, following one week of post-testing, they then trained one day per week for five weeks.  124 
Before (Pre) and after four weeks (+4 wk) and ten weeks (+10 wk) of training, the following 125 
experimental trials were conducted at least two days apart: 1) an RSA test, 2) a graded-exercise test, 126 
followed 5 min later by a square wave peak oxygen uptake (V̇O2peak) test (Pre and +4 wk only), and 3) 127 
a resting muscle biopsy.  The resting muscle biopsy Pre was conducted before the first training session, 128 
with a second biopsy (Post) taken immediately following exercise [detailed in First SIT Session (SIT1) 129 
subsection].   130 
 Participants were familiarized with all exercise tests before undertaking experimental trials.  131 
They performed two familiarization trials of the RSA test on separate days, and on another day they 132 
performed familiarization trials of the graded-exercise test and peak oxygen uptake (V̇O2peak) test.  In 133 
the week preceding the +10-wk trial, participants performed a re-familiarization of the RSA test. 134 
Insert Figure 1 here 135 
Sprint-Interval Training 136 
 The training intervention consisted of supervised, work-matched SIT performed on an 137 
electromagnetically-braked cycle ergometer (Velotron, Racer-Mate, Seattle, WA).  Participants 138 
performed a standardized 5-min steady state warm-up at 60 W, followed by 4 × 30-s sprints in the first 139 
session, increasing to a maximum of 10 × 30-s sprints in the tenth session (see Table 1 for training 140 
program).  All sprints were interspersed with either 1 min (Rest-1) or 5 min (Rest-5) of passive recovery.  141 
Training intensity was initially set at 200% of the power at the pre-training lactate threshold (LT), 142 
increasing to 305% of the pre-training LT by week 4, which was equivalent to between 121 (14)% and 143 
186 (17)% of baseline peak aerobic power (Wpeak) during the first 4 weeks.  The 13th session training 144 
intensity was adjusted to 300% of the +4 wk LT, or where necessary to avoid a reduction in intensity, 145 
adjusted to up to 350% of the LT.  This was equivalent to between 190 (13)% and 204 (14)% of the +4 146 
wk Wpeak during weeks 6 to 10.   147 
Insert Table 1 here 148 
7 
Experimental Trials 149 
All exercise and/or biopsy trials were performed in the morning (06.00–11.00) following an 150 
overnight fast, with participants recording and subsequently replicating a food diary for the 24 h prior 151 
to each exercise trial.  They were also instructed not to drink caffeine on any trial day, and to abstain 152 
from drinking alcohol or exercising in the preceding 24 h, with compliance verified by pre-trial 153 
questionnaires.  Participants were asked to maintain their normal level of activity throughout the study 154 
and completed a bespoke web-based daily training diary to monitor compliance. 155 
First SIT Session (SIT1) 156 
 To characterize both training protocols, changes in blood and muscle pH and [La−], and βm, 157 
were measured in response to the first SIT session.  The exercise bout consisted of 4 × 30-s sprints at 158 
200% LT, with either 1 min or 5 min of rest between sprints, as per group allocation.  Muscle biopsies 159 
were taken at rest before exercise (Pre) and immediately following the final sprint (Post).  Venous blood 160 
samples were taken at rest (before the muscle biopsy), and 2, 3, 5, 7, and 10 min after the final sprint.  161 
A 22 g IV cannula was inserted into an antecubital vein.  Before each sample the cannula was flushed 162 
with a small volume of sterile saline and then ~1 mL of blood was drawn into a dry syringe and 163 
discarded.  Samples were taken with the participant recumbent on a plinth.  Approximately 3 mL of 164 
blood was drawn into a heparinized syringe (Rapidlyte, Siemens Healthcare, Melbourne, VIC, 165 
Australia).  Air was immediately removed from the sample by ejecting blood into the cap and carefully 166 
tapping the syringe.  The syringe was then gently rolled to mix the sample thoroughly.  Unless the 167 
sample was ready to be analyzed without delay, the syringe was placed in an ice slurry to minimize 168 
changes in pH (23), and subsequently analyzed for blood pH (Rapidpoint 405, Siemens Healthcare, 169 
Melbourne, VIC, Australia).  Prior to this, about 0.5 mL of blood was dispensed into a microtube and 170 
immediately analyzed for lactate (2300 STAT Plus, YSI Inc., Yellow Springs, OH), or kept in an ice 171 
slurry for imminent analysis. 172 
Needle Muscle Biopsies 173 
 Muscle biopsies were taken from the belly of the vastus lateralis, approximately halfway 174 
between the knee and hip, using the needle biopsy technique modified with suction (25).  Subsequent 175 
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samples were taken approximately 1 cm from a previous biopsy site.  An incision was made under local 176 
anesthesia (1% Xylocaine) and a muscle sample taken using a Bergström needle (9).  Samples were 177 
blotted on filter paper to remove blood, before being immediately snap-frozen in liquid nitrogen and 178 
then stored at −80°C until subsequent analyses.  Muscle samples were taken from the dominant leg 179 
before (Pre) and immediately after (Post) the first training session, 3 d after the twelfth training session 180 
(+4 wk), and 3 d after the seventeenth training session (+10 wk). 181 
Repeated-Sprint Ability Test 182 
 An isokinetic RSA test was conducted on a separate day before training commenced (Pre), and 183 
after 4 weeks (+4 wk) and 10 weeks of SIT (+10 wk).  The test was performed at 110 rpm while seated 184 
on an electromagnetically-braked cycle ergometer (Excalibur Sport, Lode, Groningen, The 185 
Netherlands).  It followed the same protocol to that previously reported (63), comprising 5 × 6-s 186 
maximal sprints, separated by 24 s of rest.  During the recovery period participants remained stationary.  187 
Five seconds before the start of each sprint participants assumed the ready position – crank of the 188 
dominant leg at an angle of 45.  Initially, participants performed a 5-min steady-state warm-up at 60 189 
W, followed by 2 × 3-s practice sprints at 90% of perceived maximal effort, separated by 24 s of rest.  190 
A criterion 6-s maximal sprint was then performed 90 s later, followed by 5 min of rest prior to the RSA 191 
test.  To minimize pacing, participants were required to achieve ≥ 90% of their criterion score in the 192 
first sprint of the 5 × 6-s test.  If this criterion was not achieved, participants were required to rest for a 193 
further five minutes before restarting the test (one Rest-1 participant’s +10 data were later excluded 194 
from the analyses for failing to meet this criterion).  Before the first practice sprint, the single 6-s sprint, 195 
and the first sprint of the 5 × 6-s test, participants were required to accelerate to 110 rpm and stop 196 
pedaling instantly, followed 24 s later by the requisite sprint.  This ensured similar velocity of the 197 
flywheel before each sprint.  Consistent verbal encouragement was given throughout.  Total work and 198 
work decrement were calculated from the raw data as follows (14): 199 
work decrement (%) = (
total work − ideal work
ideal work
 × 100) 200 
where total work = actual work performed in all 5 sprints, 201 
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and ideal work = work performed in sprint number 1 × 5. 202 
Graded-Exercise Test 203 
 Graded-exercise tests were performed pre-training and at +4 wk to determine the LT from 204 
venous blood samples (taken from an antecubital vein, as described above), and Wpeak was also 205 
recorded.  Blood samples were taken at rest and at the end of every stage during the graded-exercise 206 
test.  Samples were drawn into a 3-mL dry syringe and aliquoted into a microtube for instant analysis 207 
of lactate (2300 STAT Plus, YSI Inc., Yellow Springs, OH).  The tests were performed seated on the 208 
same ergometer used for the RSA test, employing an intermittent protocol, with 4-min exercise stages 209 
and 30-s rest stages.  Beginning at 50 W, the power was subsequently increased by 25 W every 4.5 min 210 
and consistent verbal encouragement was provided for the latter stages.  Participants were required to 211 
maintain a set cadence that was self-selected during the familiarization trial and repeated for each of 212 
their subsequent graded-exercise tests.  The test was terminated either volitionally by the participant, or 213 
by the assessors when the participant could no longer maintain the required cadence (± 10 rpm), despite 214 
strong verbal encouragement.  The LT was identified as the power at which venous blood lactate 215 
increased by 1 mM above baseline, and was calculated using Lactate-E version 2.0 software (72).  Wpeak 216 
was calculated as previously reported (57): 217 
Wpeak = Wfinal + (
t
240
 × 25) 218 
where Wfinal was the power output of the last completed stage and t was the time in seconds of any final 219 
incomplete stage. 220 
Peak Oxygen Uptake Test 221 
 Immediately after the graded-exercise test, participants cycled for 5 min at 20 W, followed by 222 
a square-wave V̇O2peak test at 105% of Wpeak achieved during the graded-exercise test.  Participants were 223 
instructed to accelerate to 90–100 rpm at the commencement of a 5-s countdown, and to maintain a 224 
high, but not fixed cadence until volitional fatigue.  Consistent verbal encouragement was provided 225 
throughout.  Expired gases were analyzed every 15 s using a custom-made metabolic cart.  A two-point 226 
calibration of the gas analyzers (S-3lA/II and CD-3A analyzers, Ametek, Berwyn, PA, USA) was 227 
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performed before each test using one certified gravimetric gas (16.1% O2, 4.17% CO2; BOC Gases, 228 
Chatswood, NSW, Australia) and ambient air.  Ventilation was recorded every 15 s.  The ventilometer 229 
(KL Engineering, Sunnyvale, CA, USA) was calibrated at the start of each day using a 3-L syringe 230 
(MedGraphics, St. Paul, MN).  V̇O2peak was calculated as the mean of the two highest consecutive 15-s 231 
values.  Exercise duration was 145 (30) s [mean (SD)]. 232 
Muscle Buffer Capacity 233 
 Non-bicarbonate muscle buffer capacity (βmin vitro) was measured in duplicate on 2–3 mg dry 234 
mass (dm) of freeze-dried muscle samples using the titration technique (60).  Samples were dissected 235 
free of visible blood and connective tissue, then homogenized on ice for 3 × 30 s in a 10 mM solution 236 
of the glycolytic inhibitor NaF (0.1 mL of NaF per 3 mg dm).  pH measurements were performed at 237 
37°C with a glass microelectrode (MI-410, Microelectrodes, Bedford, NH) connected to a pH meter 238 
(Lab 850, Schott Instruments GmbH, Mainz, Germany).  After the initial pH measurement, 239 
homogenates were adjusted, if necessary, to pH 7.1–7.2 with 0.02 M NaOH, and then titrated to pH 240 
6.1–6.2 with the serial addition of 2 µL of 0.01 M HCl.  From linear regression, the number of moles 241 
of H+ required to change pH from 7.1–6.5 was interpolated, then expressed per whole pH unit and 242 
relative to sample mass.  The typical error (within-sample standard deviation) for repeat titrations was 243 
10.3 mmol H+•kg dm−1•pH−1, equivalent to a CV of 7.7% (16). 244 
 To determine the potential short-term effects of the different SIT protocols on muscle buffer 245 
capacity, non-protein βmin vitro was also assayed on the pre- and post-SIT1 samples using the titration 246 
technique (11).  Briefly, the homogenate was deproteinized with the addition of 0.03% 5-sulfosalicylic 247 
acid hydrate solution (100% w/v in 10 mM NaF), and centrifuged for 10 min at 1,000g.  Following a 248 
similar procedure to above, the pH of the supernatant was adjusted to 7.1–7.2 with the minimum volume 249 
of strong concentration NaOH, and then titrated to pH 6.1–6.2 with the serial addition of 2 µL aliquots 250 
of 5 mM HCl.  Non-protein βmin vitro was calculated as above, with the protein βmin vitro estimated from 251 
the difference between whole muscle and non-protein βmin vitro.  The typical error for repeat titrations 252 
was 6.7 mmol H+•kg dm−1•pH−1, equivalent to a CV of 10.4% (16). 253 
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Muscle Lactate Assay 254 
 Approximately 4 mg of freeze-dried pre- and post-SIT1 muscle samples were assayed 255 
enzymatically for lactate by spectrophotometric analysis (xMark microplate absorbance 256 
spectrophotometer, Bio-Rad Laboratories, Hercules, CA) using a modification of a previously described 257 
assay (75).  Samples were dissected free of visible blood and connective tissue, then homogenized in 258 
0.6 M perchloric acid using a TissueLyser II (Qiagen, Valencia, CA).  Homogenates were then 259 
centrifuged at 10,000g for 10 min at 4°C and the deproteinized supernatant removed.  1.2 M KOH and 260 
0.125 M HEPES were added and the supernatant adjusted to pH 9.0, with 3.0 M KCl then added.  261 
Following further centrifugation at 10,000g for 10 min at 4°C, the perchlorate salts were discarded and 262 
the supernatant stored at −80°C until analysis.  Lactate content was measured in triplicate against 9 263 
dilutions of a sodium lactate standard (L7022, Sigma-Aldrich, St. Louis, MI).  The typical error was 1.5 264 
mmol H+•kg dm−1, equivalent to a CV of 2.4% (15). 265 
Quantitative Western Blotting 266 
Muscle homogenate preparation 267 
 Approximately 30 mg of frozen muscle tissue were homogenized (Kontes Pellet Pestle, Kimble 268 
Chase, NJ, USA) in a 1:20 dilution of ice-cold RIPA buffer (pH 7.4) containing: 0.15 M NaCl, 1% 269 
Triton-X100, 0.5% sodium deoxycholate, 0.05 M Tris, 0.1% SDS, 1 mM EDTA, 1X 270 
protease/phosphatase inhibitor cocktail (5872, Cell Signaling Technology, Danvers, MA, USA), and 1 271 
mM PMSF.  NBCe1 was assayed in muscle tissue homogenized in a HEPES-sucrose buffer (pH 7.4) 272 
containing: 210 mM sucrose, 30 mM HEPES, 40 mM NaCl, 2 mM EGTA, 5 mM EDTA, 1% protease 273 
inhibitor cocktail (P8340, Sigma-Aldrich), 1% phosphatase inhibitor cocktail (P5726, Sigma-Aldrich), 274 
and 1 mM PMSF.  Homogenates were rotated end-over-end for 60 min at 4°C and centrifuged twice at 275 
15,000g for 10 min at 4°C.  The supernatants were collected and the pellets discarded. 276 
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Protein assay 277 
 Protein content of muscle homogenate was measured in triplicate using a Bradford assay (Bio-278 
Rad protein assay dye reagent concentrate) against serial dilutions of bovine serum albumin standards 279 
(A9647, Sigma-Aldrich). 280 
Immunoblotting 281 
 Immunoblotting for each antibody has been previously described in detail, including validation 282 
steps taken for specific antibodies (63).  Briefly, homogenate was diluted in Laemmli buffer and equal 283 
amounts of total protein (1–25 µg) were loaded in different wells on 10% or 12% Tris-Glycine-HCl 284 
SDS-PAGE gels, or in Criterion 4–12% Bis-Tris SDS-PAGE gels (Bio-Rad) for NBCe1 and CAIV.  285 
All samples for a participant were loaded on the same gel.  Five or six different dilutions of a mixed-286 
homogenate internal standard were also loaded on every gel and a calibration curve plotted of density 287 
against protein amount.  From the subsequent linear regression equation, protein abundance was 288 
calculated from the measured band intensity for each sample on the gel (68).  Coomassie blue (Phastgel 289 
Blue R-350, GE Healthcare, Rydalmere, NSW, Australia) staining of total protein was used as a loading 290 
control. 291 
 Gel electrophoresis ran for 60–80 min at 100 V or 140 V, and proteins were then wet-transferred 292 
at 100 V to a 0.2 µm polyvinylidene fluoride membrane.  Membranes were blocked for 60 min at room 293 
temperature in 5% non-fat dry milk diluted in Tris-buffered saline with 0.1% Tween-20 (TBST).  294 
Following TBST wash steps, membranes were incubated either overnight or for 2 h with the appropriate 295 
primary antibody (see Table 2 for conditions).  After further TBST washes, the membranes were 296 
incubated for 90 min at room temperature in the appropriate secondary antibody.  After further washes, 297 
membranes were incubated in chemiluminescent solution for 2 min and images were taken with a 298 
VersaDoc Imaging System (Bio-Rad, Hercules, CA) fitted with a CCD camera (Bio-Rad).  299 
Densitometry was performed with Image Lab 5.0 software (Bio-Rad) using the volume calculation and 300 
background correction was applied individually to each lane using a rolling-ball algorithm.  Images of 301 
example blots are displayed in their entirety, except where membranes were cut as described.  CVs of 302 
replicate gels for individual proteins are presented in their respective figure captions. 303 
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A Pre sample for one Rest-5 participant was blood contaminated, necessitating exclusion of her 304 
western blot data for MCT1, NHE1, NBCe1, and CAII.  In addition, there was insufficient muscle 305 
biopsied to allow analyses of all proteins for another Rest-5 participant’s +10 wk sample.  306 
Consequently, there are no +10 wk data for CAIV, CAXIV, and NBCe1 for this participant.  Finally, 307 
in analyzing NBCe1 at +10 wk for one Rest-1 participant, the signal for this band was below the 308 
threshold of detection.  309 
Insert Table 2 here 310 
Statistical Analyses 311 
 Measures of centrality and dispersion are mean (SD) unless otherwise stated.  To reduce bias 312 
from non-uniformity of error, data were logarithmically-transformed where heteroscedasticity was 313 
present (70), such as for western blot data.  For these data, geometric mean and standard deviation are 314 
reported (geometric mean ×/÷SD).  Data were analyzed using linear mixed models with, for example, 315 
‘time’ (repeated-measure), ‘group’, and ‘group×time’ as fixed factors; and ‘subject’ and ‘intercept’ as 316 
random factors.  First-order autoregressive covariance structures were used for all models and model 317 
fit was assessed by −2 log-likelihood (26).  Effect sizes (ES) were assessed using Cohen’s d, with ES 318 
thresholds defined as trivial < 0.2, small < 0.6, moderate < 1.2, large < 2.0, very large < 4.0, and 319 
extremely large ≥ 4.0 (45).  Uncertainty of effects is expressed as 90% confidence limits (90% CL) and 320 
P values, with the latter presented as precise values unless P < 0.001 (19).  Effects were not considered 321 
meaningful if there was < 75% probability of being substantially positive relative to the smallest 322 
worthwhile change (ES = 0.2), and were deemed unclear if there was a greater than 5% probability of 323 
also being substantially negative (44, 45).  If no between-group differences were found, within-group 324 
effects are reported for pooled group data.  Linear mixed models were analyzed using IBM SPSS 325 
Statistics V21 (IBM Corporation, Somers, NY, USA), and effect sizes and confidence limits were 326 
calculated using custom Excel spreadsheets (44).  Total work performed by the two groups during the 327 
training intervention was compared by an independent sample, unequal variance t test, and by effect 328 




Training Data 332 
 Both training groups performed similar volumes of total work throughout the training 333 
intervention, 1.19 (0.15) MJ and 1.15 (0.23) MJ for Rest-1 and Rest-5, respectively (t12 = 0.37, P = 334 
0.72, ES: 0.18; 90% CL ±0.90).  There was excellent training compliance, with only a single training 335 
session being missed by one participant.  336 
Physiological Responses to SIT1 337 
 Short-term physiological responses to SIT1 are shown in Figure 2 and Figure 3.  Following 338 
SIT1, muscle [La−] increased to 84.2 (20.3) mmol•kg dm−1 and 61.8 (31.9) mmol•kg dm−1 for Rest-1 339 
and Rest-5, respectively (time main effect: F1,15 = 209.26, P < 0.001, pooled ES: 5.49, 90% CL ×/÷0.72), 340 
but there was no clear difference between groups (group×time interaction: F1,15 = 0.86, P = 0.37, ES: 341 
0.70, ×/÷1.42).  Assuming a muscle water content of 3.3 L•kg dm−1 (48), this equates to 25.5 (6.2) mM 342 
and 18.7 (9.7) mM for Rest-1 and Rest-5.  Muscle pH decreased more for Rest-1, 6.92 (0.11) to 6.53 343 
(0.14), than Rest-5, 6.89 (0.13) to 6.63 (0.18) (group×time interaction: F1,15 = 3.50, P = 0.08, ES: 1.07; 344 
±1.11).   345 
 Mean βmin vitro did not change for either group following SIT1 (time main effect: F1,15 = 0.008, 346 
P = 0.93, pooled ES: 0.03; ±0.65).  βmin vitro was lower Pre for Rest-5 than Rest-1, 146.7 (11.4) and 347 
134.8 (9.5) mmol H+•kg dm−1•pH−1, respectively (group main effect: F1,15 = 14.4, P = 0.002, Pre ES: 348 
1.06; ±1.37).  There was also no change in mean non-protein βmin vitro after SIT1 (time main effect: F1,15 349 
= 0.66, P = 0.43, pooled ES: 0.29; ±0.63); nor was there a meaningful difference between groups (group 350 
main effect: F1,15 = 1.92, P = 0.19, ES: 0.48; ±1.36).  The measured non-protein βmin vitro at rest was 62.6 351 
(8.0) mmol H+•kg dm−1•pH−1, which was 44 (6)% of total βmin vitro (range: 34% to 59%).  Therefore, the 352 
estimated protein βmin vitro was 76.5 (9.1) mmol H+•kg dm−1•pH−1. 353 
Insert Figure 2 here 354 
 Venous blood pH decreased from 7.36 (0.03) Pre to 7.21 (0.07) at +2 min following SIT1 (time 355 
main effect: F5,68.4 = 34.1, P < 0.001).  There were no clear differences in blood pH between the two 356 
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groups (group×time interaction: F5,68.4 = 0.48, P = 0.79) due to the high within-group variability 357 
(between-group +2 min ES: 0.97; ±2.13).  Mean venous blood [La−] peaked at +7 min (6.60 mM and 358 
5.50 mM for Rest-1 and Rest-5), with a greater increase apparent for Rest-1 at +5 min and +7 min 359 
(group×time interaction: F5,64.7 = 2.77, P = 0.025, +5 min ES: 1.08, ×/÷1.12, +7 min ES: 1.24, ×/÷1.16). 360 
Insert Figure 3 here 361 
Protein Abundance 362 
MCT1 363 
 The MCT1 antibody recognized a single band at approximately 50 kDa (Fig 4A).  MCT1 364 
protein content did not differ between the two groups (group×time interaction: F2,25.2 = 0.17, P = 0.84, 365 
+4 wk ES: 0.04, ×/÷0.57).  On pooling the data there was an increase at +4 wk of 1.18-fold ×/÷1.23 366 
(time main effect: F2,25.2 = 3.18 P = 0.06, ES: 0.44, ×/÷0.27).  Comparing the pooled difference scores 367 
from +4 wk to +10 wk, i.e. when training volume reduced from 3 d to 1 d per week, there was no change 368 
in mean MCT1 abundance (ES: −0.13, ×/÷0.37). 369 
MCT4 370 
 The MCT4 antibody recognized a strong band at ~50 kDa and a weaker band at ~75 kDa in 371 
some samples (Fig 4B); only the 50 kDa band was quantified.  There were no differences between the 372 
two groups (group×time interaction: F2,28.1 = 0.30, P = 0.74, +4 wk ES: 0.21, ×/÷0.82).  Overall, mean 373 
MCT4 abundance did not change in response to training (time main effect: F2, 28.1 = 0.46, P = 0.64, 374 
pooled +4 wk ES: 0.09, ×/÷0.39).   375 
Basigin 376 
 The basigin antibody detected a single band just above 37 kDa (Fig 4C), likely the canonical 377 
basigin-2 isoform (63).  Basigin content did not differ between the two groups (group×time interaction: 378 
F2,28.3 = 0.20, P = 0.82, +4 wk ES: 0.06, ×/÷0.61).  On pooling the data there were no meaningful changes 379 
(time main effect: F2,28.3 = 3.04, P = 0.06, +4 wk ES: 0.30, ×/÷0.29, +10 wk ES: 0.02, ×/÷0.31). 380 
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NHE1 381 
 The NHE1 antibody recognized a single or a double band just below 100 kDa (Fig. 4D).  The 382 
predicted molecular mass of NHE1 is 91 kDa, therefore it is probable that the identified band(s) 383 
represent non- or partially-glycosylated NHE1 protein (39).  As per previous reports, both bands were 384 
quantified if present (55).  Overall there was an increase in NHE1 abundance following training (time 385 
main effect: F2,25.3 = 4.00, P = 0.03, pooled +4 wk ES: 0.57, ×/÷0.33).  The two groups responded 386 
differently to training (group×time interaction: F2, 25.3 = 5.23, P = 0.013).  There were similar increases 387 
at +4 wk of 1.11-fold ×/÷1.09 and 1.15-fold ×/÷1.22, for Rest-1 and Rest-5 respectively (ES: 0.16, 388 
×/÷0.80), but when training volume was reduced to 1 d per week NHE1 decreased to baseline for Rest-389 
1, while for Rest-5 NHE1 increased 1.44-fold ×/÷1.18 compared to baseline (+10 wk ES: 1.68, ×/÷0.97). 390 
Insert Figure 4 here 391 
NBCe1 392 
 The NBCe1 antibody recognized a band close to the predicted molecular mass of 121 kDa for 393 
the canonical NBCe1-B splice variant (Fig. 5).  Stronger signal bands of unknown origin were also 394 
detected at about 50 kDa and 75 kDa; only the ~120 kDa band was quantified (63).  Overall there was 395 
no meaningful change in NBCe1 abundance following training (time main effect: F2,17.8 = 0.23, P = 396 
0.80, pooled +4 wk ES: 0.15, ×/÷0.38).  Mean NBCe1 content increased for Rest-1 (1.30-fold ×/÷1.55) 397 
and decreased for Rest-5 (0.89-fold ×/÷1.47) after 4 weeks of SIT due to high individual 398 
variability/outliers (group×time interaction: F2,17.8 = 1.14, P = 0.34, +4 wk ES: 0.64, ×/÷0.72).  There 399 
was no meaningful difference between groups at +10 wk (ES: 0.42, ×/÷0.94). 400 
Insert Figure 5 here 401 
CAII 402 
 The CAII antibody recognized a single band just above 25 kDa (Fig. 6A).  There was no 403 
difference between groups in CAII content over time (group×time interaction: F2,24.9 = 0.08, P = 0.92, 404 
+4 wk ES: 0.09, ×/÷0.64).  On pooling the data CAII content decreased 0.92-fold ×/÷1.11 following 405 
training (time main effect: F2,24.9 = 3.79, P = 0.04, +4 wk ES: −0.47, ×/÷0.31). 406 
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CAIII 407 
 The CAIII antibody recognized a single band just above 25 kDa (Fig. 6B).  There was no overall 408 
change in CAIII content for the two groups (time main effect: F2,26.9 = 0.32, P = 0.73, pooled +4 wk ES: 409 
0.19, ×/÷0.42).  There was no difference between the two groups after four weeks training (group×time 410 
interaction: F2,26.9 = 1.74, P = 0.20, ES: 0.26, ×/÷0.91).  At +10 wk the difference between groups was 411 
unclear (ES: 1.04, ×/÷1.42). 412 
CAIV 413 
 The CAIV antibody had poor signal-to-noise ratio but recognized a single or double band near 414 
the predicted molecular mass of 35 kDa (Fig. 6C) in the muscle homogenate and positive control (293T 415 
Cell Transient Overexpression Lysate, Abnova, Taipei, Taiwan).  The CAIV response to training did 416 
not differ between the two groups (group×time interaction: F2,18.6 = 0.26, P = 0.77, +4 wk ES: 0.01, 417 
×/÷1.06).  On pooling the data, CAIV content progressively decreased following training, 0.87-fold 418 
×/÷1.40 and 0.79-fold ×/÷1.36 at +4 wk and +10 wk, respectively (time main effect: F2,18.6 = 3.50, P = 419 
0.051, pooled +4 wk ES: −0.39, ×/÷0.47, +10 wk ES −0.72, ×/÷0.46). 420 
CAXIV 421 
 The CAXIV antibody recognized a single band below 50 kDa in the muscle homogenate and 422 
the positive control (Fig. 6D).  There was no difference between groups in the CAXIV response 423 
(group×time interaction: F2,26.0 = 0.40, P = 0.68, +4 wk ES: 0.08, ×/÷0.96).  Overall CAXIV abundance 424 
increased in response to training 1.63-fold ×/÷1.66 (time main effect: F2,26.0 = 5.77, P = 0.008, pooled 425 
+4 wk ES: 1.00, ×/÷0.49).  After SIT volume was reduced to 1 d per week, mean CAXIV abundance 426 
decreased to baseline values (pooled +10 wk ES: 0.20, ×/÷0.62). 427 
Insert Figure 6 here 428 
Muscle Buffer Capacity 429 
 βmin vitro did not change in response to training for either group (Fig. 7) (time main effect: F2,32.0 430 
= 0.11, P = 0.89, pooled +4 wk ES: 0.11; ±0.39).  As noted above, βmin vitro was lower throughout for 431 
Rest-5 (group main effect: F1,15 = 14.4, P = 0.002, Pre ES: −1.06; ±0.87). 432 
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Insert Figure 7 here 433 
Repeated-Sprint Ability 434 
 Total work performed during the RSA test improved only in the Rest-5 group (Fig. 8A) 435 
(group×time interaction: F2,27.0 = 4.60, P = 0.02, +4 wk ES: 0.51; ±0.37).  On reducing SIT volume to 436 
1 d per week, total work for Rest-5 decreased slightly from 13.9 (2.2) kJ to 13.5 (2.6) kJ, while for Rest-437 
1 it did not change from 14.0 (2.1) kJ at +4 wk to 14.0 (2.5) kJ at +10 wk.  Hence, there was still a clear 438 
difference between groups at +10 wk (ES: 0.42; ±0.50).  Comparing the change in work performed 439 
during each individual sprint (Fig. 8C), Rest-5 had better improvements for the last three sprints at +4 440 
wk compared to Rest-1 (Sprint 3 ES: 0.57; ±0.49, Sprint 4 ES: 0.78; ±0.50, Sprint 5 ES: 0.51; ±0.46).  441 
For both groups work decrement during the RSA test improved following four weeks of training (Fig. 442 
8B) (time main effect: F2,27.4 = 9.57, P = 0.001, pooled +4 wk ES: 0.95; ±0.52).  There were no clear 443 
differences between the two groups (group×time interaction: F2,27.4 = 1.84, P = 0.18, +4 wk ES: 0.67; 444 
±1.05, +10 wk ES: 0.04; ±1.08).  There was no difference between the pooled +4 wk and +10 wk data, 445 
indicating that better work decrement was maintained with 1 d per week training (pooled ES: −0.20; 446 
±0.32).   447 
Insert Figure 8 here 448 
Aerobic Capacity 449 
 Power at the LT changed little in response to training for either group (Fig. 9A) (time main 450 
effect: F1,14 = 2.47, P = 0.14, pooled ES: 0.24; ±0.59).  There was also no clear difference between the 451 
two groups (group×time interaction: F1,14 = 1.79, P = 0.20, ES: 0.41; ±0.59).  As with the LT, mean 452 
Wpeak did not change with training (Fig. 9B) (time main effect: F1,14 = 2.84, P = 0.11, pooled ES: 0.19; 453 
±0.21), nor was there a difference between the two groups (group×time interaction: F1,14 = 0.23, P = 454 
0.64, ES: 0.10; ±0.42).  V̇O2peak did not change differently between the two groups (Fig. 9C) 455 
(group×time interaction: F1,14 = 0.01, P = 0.91, ES: 0.03; ±0.44).  On pooling the data there was a small 456 
increase in V̇O2peak of 2.2 mL•min
−1•kg−1 (90% CL ±1.1 mL•min−1•kg−1) (time main effect: F1,14 = 12.00, 457 
P = 0.004, pooled ES: 0.38; ±0.20). 458 
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Insert Figure 9 here 459 
Discussion 460 
 This study provides a comprehensive analysis of the acid/base transport protein response to SIT 461 
in active women.  Our main finding was that selective upregulation of these proteins was evident 462 
following SIT, but manipulation of rest interval duration (1 or 5 min) did not influence the adaptive 463 
response.  Increased abundance of MCT1, NHE1, and CAXIV was seen after 4 weeks, with either no 464 
change or a decrease evident for MCT4, NBCe1, basigin, CAII, CAIII, and CAIV.  There was also no 465 
change in βmin vitro.  Greater improvements in RSA were seen with Rest-5 compared to Rest-1, while 466 
both groups had similar improvements in aerobic capacity.  A second major finding was that enhanced 467 
protein abundance and RSA were maintained when training volume was reduced to 1 d per week, 468 
although disparate responses between groups were seen for NHE1.  Overall, these data demonstrate that 469 
short-term, supramaximal-intensity exercise has modest effects on pH-regulatory components 470 
compared to, for example, the rapid mitochondrial remodeling reported following SIT (30).   471 
 MCT1 protein content increased for both Rest-1 and Rest-5, but in common with most studies 472 
there were no changes in MCT4 protein content following 4 weeks of SIT (3, 10, 32, 49, 66, 76).  473 
Although the signaling factors responsible for regulation of the MCTs in vivo remain to be determined, 474 
the current study supports the existing in vitro evidence that they respond to distinct stimuli (34, 38, 475 
79).  For example, increased content of MCT1, but not MCT4, has been shown in L6 cells 1 h after 476 
incubation with either 10 mM or 20 mM La− (38).  In our study, immediately after SIT1 muscle [La−] 477 
increased to 25.5 (6.2) mM and 18.7 (9.7) mM for Rest-1 and Rest-5, respectively.  Therefore, consistent 478 
with in vitro data (38), intracellular La− accumulation may be a stimulus for MCT1, but not MCT4 479 
upregulation, in human skeletal muscle.  However, given the similar increase in MCT1 abundance for 480 
both groups, and that exercise-induced decreases in pHi differed by only ~0.1 pH unit following SIT1, 481 
our data prove inconclusive as to whether H+ accumulation is an important signal for inducing MCT1 482 
expression.  The absence of any change in MCT4 abundance indicates that neither La− nor H+ 483 
accumulation are likely to be important signaling factors in MCT4 regulation.  484 
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 The factors affecting regulation of the MCT chaperone protein basigin in human skeletal 485 
muscle have not been described.  The present study provides the first investigation of the response of 486 
basigin to a SIT intervention, finding no meaningful changes in protein abundance after 4 or 10 weeks 487 
of training for either group.  Given the substantial increase in muscle [La−] following both Rest-1 and 488 
Rest-5 noted above, these results contrast with previous data from L6 cells (38), whereby basigin protein 489 
content was increased by 1.85-fold to 2.78-fold after 1 h of La− incubation (10 or 20 mM), but decreased 490 
after 6–48 h of incubation.  However, an difference between the cell model and exercising human 491 
muscle is that prolonged [La−] of 10 mM or 20 mM are not physiological in human muscle in vivo.  492 
While accumulation of similar levels of intracellular La− was found in the present study, and is typical 493 
of high-intensity exercise, activity of the MCTs causes La− efflux from the cytosol, resulting in 494 
oxidation of La− to pyruvate or entry of La− into the Cori cycle for gluconeogenesis (24).  Thus, while 495 
prolonged high [La−] may stimulate an increase in basigin content in L6 cells, the present data suggest 496 
the high [La−] typical of SIT does not provoke increases in basigin content in exercising human muscle.  497 
 Second to the MCTs, NHE1 provides the next most important contribution to H+ efflux during 498 
high-intensity exercise (4, 5).  This study found small increases in NHE1 abundance after four weeks 499 
of SIT for Rest-1 (1.12-fold ×/÷1.09) and Rest-5 (1.13-fold ×/÷1.22).  All of the research to date on the 500 
NHE1 protein response to training has emanated from Copenhagen (3, 32, 33, 49, 54, 66, 78, 81), with 501 
mean fold-change following SIT/HIIT interventions ranging from 0.95-fold (81) to 1.35-fold (78).  The 502 
one study to include females, in a group consisting of both sexes, found a 1.14-fold increase with 503 
training (32).  Thus, it seems while NHE1 abundance may increase following HIIT/SIT in different 504 
populations, the magnitude of any increase is typically small.  An unexpected finding in the current 505 
study was a further increase in NHE1 content for Rest-5 of 1.25-fold ×/÷1.23, compared to +4 wk, after 506 
SIT volume was reduced to 1 d per week.  In contrast, NHE1 abundance returned to baseline for Rest-507 
1, indicating the stress imposed by the two training regimens differentially induced NHE1, but only 508 
when training load was reduced.  One study has shown NHE1 abundance to increase 1.35-fold in elite 509 
footballers who stopped training for 2 weeks at the end of their season, in contrast to a group who 510 
performed 2 weeks of mixed HIIT/SIT (81).  It appears that following a period of intensive training, a 511 
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reduced training stimulus is favorable for NHE1 upregulation.  This may relate to the long fractional 512 
degradation rate for NHE1 mRNA, whereby steady-state mRNA content is not apparent until 24–48 h 513 
post-HIIT (62).  If there is a subsequent delay in protein synthesis, then upregulation of NHE1 may 514 
benefit from a longer duration between exercise sessions.  Further evidence is required to confirm this. 515 
 The NBCe1 protein response to a SIT intervention has been reported here for the first time.  516 
Although no changes in mean NBCe1 content were seen for either group, there were highly variable 517 
responses.  We previously found NBCe1 abundance to increase in men undergoing 4 weeks of HIIT 518 
performed at different intensities between the LT and Wpeak (63).  Using a non-isoform specific 519 
antibody, others have reported NBC content to increase in rat soleus following 5 weeks of HIIT, 520 
regardless of whether rats received sodium bicarbonate or a placebo prior to each training session (80).  521 
By buffering extracellular H+, sodium bicarbonate enhances H+ efflux by creating a greater pH gradient 522 
relative to the intracellular space (58).  In the current study, 5 min of rest would also have enabled 523 
greater H+ efflux compared to 1 min of rest.  Therefore, from these limited data it seems that H+ efflux 524 
does not influence changes in NBC(e1) protein content.  While there may be sex-specific responses on 525 
comparing our two human studies, it seems that longer duration intervals of high-intensity training may 526 
be required to provoke adaptations in NBC(e1).  The signaling factors required for regulation of NBCe1 527 
in human muscle in vivo are unknown, but in vitro research has shown that IRBIT (inositol 1,4,5 528 
trisphosphate receptor binding protein released with inositol 1,4,5 trisphosphate) activates most of the 529 
NCBT proteins, except for NBCe2 (73).  Whether IRBIT is important in vivo remains to be shown, but 530 
it is a potential target for future study. 531 
 There were contrasting changes in each of the CA isozymes after four weeks of training.  Of 532 
the cytosolic CAs, CAII content decreased slightly for both groups, whereas there was no change in 533 
CAIII content.  Of the sarcolemmal CAs, there were large increases in CAXIV abundance for both 534 
Rest-1 and Rest-5, but a small decrease in CAIV content for both groups at +4 wk.  There are no 535 
published data on the CA response to SIT, although we reported increases in CAII and CAXIV content, 536 
but decreases or no change in CAIII or CAIV, following four weeks of 2-min HIIT in men (63).  Given 537 
there were no differences between groups in the present study, despite differing metabolic stresses 538 
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imposed by 1-min versus 5-min rest intervals, nor after differing intensities of HIIT (63), there is little 539 
insight as to the potential mechanisms for regulation of CA content.   540 
 There were no changes in βmin vitro for either group following 4 or 10 weeks of SIT.  Previous 541 
research postulated that H+ accumulation might be a stimulus for upregulation of βmin vitro (21, 83).  If 542 
so, then βmin vitro might have been expected to improve more for Rest-1 because the shorter rest intervals 543 
would prevent recovery of pHi between sprints.  As expected, muscle pH was lower for Rest-1 than 544 
Rest-5, but given there were no improvements in βmin vitro for either group, the low muscle pH associated 545 
with both types of training was not a factor in improving βmin vitro.  These data add to the existing 546 
evidence showing improvements in βmin vitro are typically not found with short-duration work intervals 547 
(2, 20, 37, 49, 71). 548 
 To profile the metabolic stress imposed by the two exercise bouts, we also assayed total and 549 
non-protein βmin vitro before and after the first bout of SIT.  While a small reduction in βmin vitro might 550 
theoretically be expected post-exercise due to the greater content of organic phosphates and lower free 551 
Pi content, mean non-protein βmin vitro changed little.  The randomness of individual responses suggests 552 
methodological rather than physiological variation.  Our group has previously reported lower βmin vitro 553 
immediately after various bouts of high-intensity exercise (11, 13).  In one study, because non-protein 554 
βmin vitro was unchanged, the lower total βmin vitro was inferred to be due to reduced protein buffering 555 
(11).  However, in the current study, with no change in either total βmin vitro or non-protein βmin vitro, there 556 
was consequently no change in estimated protein βmin vitro.  Therefore, the present data cast doubt on 557 
whether a short-term reduction in protein buffering is likely immediately following high-intensity 558 
exercise.  This adds to our data questioning the sensitivity and ecological validity of the titration assay 559 
(62).  Notwithstanding these concerns, our estimated protein βmin vitro of 76.5 (9.1) mmol H+•kg 560 
dm−1•pH−1, or 23.2 (2.8) mmol•L−1•pH−1, is similar to the 26 mmol•L−1•pH−1 predicted from the 561 
Henderson–Hasselbalch equation for protein-bound histidine (48). 562 
 We anticipated that performance improvements would be specific to training that more closely 563 
matched the substrate usage of the exercise test; however, not all the performance improvements were 564 
as expected.  RSA did improve more for Rest-5, with greater total work performed and better fatigue 565 
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resistance.  This was not due to improved single (i.e. first) sprint performance, but to progressively 566 
greater total work performed in sequential sprints at +4 wk compared to Pre.  Greater total work 567 
probably relates to an enhanced anaerobic capacity providing greater relative substrate level 568 
phosphorylation for sequential sprints, in part because of improved PCr resynthesis (12).  Rest-1 had 569 
no improvement in total work, but did have improved fatigue resistance because of a lower reduction 570 
in work for the later sprints.  Better fatigue resistance more likely reflects that the ability to sustain 571 
power for later sprints is dependent on oxidative rather than glycolytic capacity (61).  Accordingly, both 572 
groups displayed similarly modest improvements in V̇O2peak of ~6%, or 2.2 mL•min
−1•kg−1 (90% CL 573 
±2.4 mL•min−1•kg−1), and 2.1 ±1.0 mL•min−1•kg−1, for Rest-1 and Rest-5, respectively.  These data are 574 
less than the aggregate reported in a meta-analysis of SIT studies of 8%, or 3.6 mL•min−1•kg−1 (31), but 575 
greater than the 3.6% improvement in a subgroup analysis of non-athletic active females, reported in a 576 
separate meta-analysis (85).  It appears that short-duration SIT interventions produce only moderate 577 
improvements in V̇O2peak in active women.  Finally, there were no group mean improvements in the LT 578 
or Wpeak for Rest-1 or Rest-5, but there was notable individual variability within both groups.  Those 579 
factors determining the individual training response require further research (59), with particular 580 
emphasis on study design to enable making robust inferences (1, 40). 581 
 We have shown that adaptations in some acid/base transport proteins can be maintained by a 582 
reduction in training volume for a subsequent 5-week period of similar intensity SIT.  One unexpected 583 
finding was that NHE1 protein content increased further for Rest-5 after reducing SIT volume to one 584 
day per week.  Why this occurred is uncertain, but it may be that with comparatively long mRNA and 585 
protein half-lives (62), NHE1 protein synthesis peaks with longer recovery between training sessions.  586 
Finally, improved performance was evident during the RSA test for both groups, but to different 587 
degrees.  On comparing total work and work decrement at +10 wk and +4 wk there were no differences, 588 
demonstrating that where RSA was enhanced after 4 weeks of training, it was maintained with just one 589 
day per week of training at a similar intensity.  This confirms that once performance adaptations are 590 
achieved with a short period of intensified training, they can be readily maintained with a lower volume 591 
of high-intensity training (41, 42, 46, 47, 67). 592 
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 593 
Perspectives and Significance 594 
Selective upregulation of acid/base transport proteins was found in active women after 4 weeks 595 
of SIT.  The similar adaptations of two work-matched training groups, differing only in rest intervals 596 
of 1 or 5 min, indicates duration of recovery does not influence short-term adaptations in these proteins, 597 
at least not in an active female population. We also report evidence supporting lactate as a signaling 598 
molecule for inducing MCT1, but not MCT4 expression.  Furthermore, four weeks of SIT produced 599 
only modest improvements in V̇O2peak, indicating there was insufficient training volume to produce the 600 
primarily central adaptations that determine V̇O2peak.  Overall, there was little change in mean LT or 601 
Wpeak, but possible evidence of high- and low-responders in both groups merits further exploration.  602 
Meanwhile there were better improvements in RSA for Rest-5, likely reflecting the greater anaerobic 603 
training stimulus provided by longer rest intervals.  Finally, maintaining the physiological stimulus of 604 
training intensity, but reducing the volume of training, was sufficient to mitigate reversal of adaptations 605 
for acid/base transport proteins and RSA.  The implication from this research is that rest intervals of 5 606 
minutes during SIT lead to better improvements in RSA than 1-minute rest intervals, and these 607 
improvements can be maintained despite a reduction in the volume of SIT performed. 608 
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Figure Captions 832 
Figure 1 Experimental design.  Abbreviations: GXT (graded-exercise test); RSA (repeated-sprint ability 833 
test); SIT1 (sprint-interval training session 1). 834 
Figure 2 (A) Muscle pH, (B) muscle lactate, (C) total βmin vitro (non-bicarbonate muscle buffer capacity), 835 
and (D) non-protein βmin vitro before (Pre) and immediately after (Post) a single bout of sprint-interval 836 
training (SIT1) for Rest-1 (triangles, n = 7) and Rest-5 (circles, n = 8; including one participant who 837 
dropped out after SIT1).  Individual data points are plotted.  CV of duplicate samples: pH (0.6%), lactate 838 
(3.8%), total βmin vitro (6%), and non-protein βmin vitro (8%).   839 
Figure 3 (A) Venous blood pH, and (B) venous lactate before (Pre) and 2, 3, 5, 7, and 10 min after a 840 
single bout of sprint-interval training (SIT1) for Rest-1 (triangles, n = 7) and Rest-5 (circles, n = 8; 841 
including one participant who dropped out after SIT1).  Data are mean (SD).  CV of duplicate samples: 842 
pH (0.05%), lactate (5.3%). 843 
Figure 4 Representative immunoblots and protein abundance of (A) MCT1, (B) MCT4, (C) basigin, 844 
and (D) NHE1 before (Pre) and after 4 weeks (+4 wk) and 10 weeks (+10 wk) of sprint interval training 845 
(SIT) for Rest-1 and Rest-5.  Protein abundance is relative to a calibration curve for a mixed-846 
homogenate internal standard run on every gel.  Individual data points and geometric means (horizontal 847 
bars) are plotted.  Non-adjacent lanes from the same blots are indicated by vertical lines (A, B, and D).  848 
CV of duplicate or triplicate gels: MCT1 (16%), MCT4 (16%), basigin (11%), and NHE1 (15%). 849 
Figure 5 (A) Representative immunoblot and (B) NBCe1 protein abundance before (Pre) and after 4 850 
weeks (+4 wk) and 10 weeks (+10 wk) of sprint interval training (SIT) for Rest-1 and Rest-5.  Protein 851 
abundance is relative to a calibration curve for a mixed-homogenate internal standard run on every gel.  852 
Individual data points and geometric means (horizontal bars) are plotted.  CV of duplicate gels was 853 
26%. 854 
Figure 6 Representative immunoblots and protein abundance of (A) CAII, (B) CAIII, (C) CAIV, and 855 
(D) CAXIV before (Pre) and after 4 weeks (+4 wk) and 10 weeks (+10 wk) of sprint interval training 856 
(SIT) for Rest-1 and Rest-5.  Protein abundance is relative to a calibration curve for a mixed-857 
36 
homogenate internal standard run on every gel.  Individual data points and geometric means (horizontal 858 
bars) are plotted.  Positive controls (+ve) were loaded for CAIV and CAXIV.  Non-adjacent lanes from 859 
the same blots are indicated by vertical lines (A and D).  CV of duplicate or triplicate gels: CAII (15%), 860 
CAIII (single gels), CAIV (23%), and CAXIV (29%). 861 
Figure 7 Non-bicarbonate muscle buffer capacity (βmin vitro) before (Pre) and after 4 weeks (+4 wk) and 862 
10 weeks (+10 wk) of sprint interval training(SIT) for Rest-1 and Rest-5.  Individual data points are 863 
plotted.  CV of duplicate titrations = 7.7%. 864 
Figure 8 (A) Total work and (B) work decrement during a repeated-sprint ability test (5 × 6 s) before 865 
(Pre) and after 4 weeks (+4 wk) and 10 weeks (+10 wk) of sprint interval training (SIT) for Rest-1 and 866 
Rest-5 (individual data points), and (C) work performed per individual sprint for Rest-1 (triangles) and 867 
Rest-5 (circles) at Pre and +4 wk [mean (SD)]. 868 
Figure 9 (A) Lactate threshold, (B) peak aerobic power (Wpeak), and (C) peak oxygen uptake (V̇O2peak) 869 
before (Pre) and after 4 weeks (+4 wk) of sprint interval training (SIT) for Rest-1 and Rest-5.  Individual 870 
data points are plotted. 871 
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Tables 873 
Table 1 Title 874 
Sprint-interval training programs performed by the 1-min rest (Rest-1) and 5-min rest (Rest-5) 875 
training groups 876 
Table 1 Legend 877 
Relative intensity for weeks 1 to 4 was calculated as a percentage of the lactate threshold (LT) 878 
determined during the pre-training graded-exercise test.  Relative intensity for weeks 6 to 10 was 879 
calculated as a percentage of the LT determined during the +4 wk graded-exercise test.  Data are mean 880 
(SD). 881 
 882 
Table 2 Title 883 
Details of primary and secondary antibodies used for western blotting 884 
